Eli Lilly and Co announced that they will sell a half-price version of the popular insulin injection Humalog. The new product will be called Insulin Lispro; Humalog will remain available for those who wish to use it through existing insurance plans. The move comes as many major drugmakers, including Lilly, have received criticism from patients and lawmakers over the rising cost of insulin. Read more